Agoracom: Small Cap Investment - Zenith Epigenetics - Re: More sites now recruiting for ZEN003694 NCT02705469 trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

More sites now recruiting for ZEN003694 NCT02705469 trial

BearDownAZ

Jun 09, 2016 01:27PM

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

Jkj193741

Jun 09, 2016 02:18PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

in response to

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

Jkj193741

posted on Jun 09, 2016 02:31PM

If you doubt Zenith's patent protection, I suggest you contact them. I am assuming after what happened with ZEN003365, that IP protection has been a priority for Zenith.

BearDownAZ

2 Recommendations

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

Jkj193741

Jun 09, 2016 05:56PM

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

Toinv

Jun 09, 2016 06:46PM

Re: More sites now recruiting for ZEN003694 NCT02705469 trial

Jkj193741

Jun 09, 2016 08:31PM

Re: More sites now recruiting for ZEN003694 NCT02705469 trial